Curcumin, Omeprazole Similarly Effective for Functional Dyspepsia

TUESDAY, Sept. 12, 2023 (HealthDay News) -- Curcumin and omeprazole have similar efficacy for functional dyspepsia, according to a study published online Sept. 11 in BMJ Evidence-Based Medicine.
Pradermchai Kongkam, M.D., from the Chulalongkorn University Faculty of Medicine in Bangkok, and colleagues conducted a randomized trial to compare the efficacy of curcumin versus omeprazole for patient-reported outcomes among participants with a diagnosis of functional dyspepsia. Two hundred six patients were randomly assigned to one of three groups: curcumin alone (C), omeprazole alone (O), and curcumin plus omeprazole (C+O). The Severity of Dyspepsia Assessment (SODA) score was used to assess symptoms of functional dyspepsia on days 28 and 56.
The researchers found that on day 28, there were significant improvements in SODA scores in the pain, nonpain, and satisfaction categories for the C+O, C, and O groups. On day 56, these improvements were enhanced in the pain, nonpain, and satisfaction categories in all groups. There were no significant differences seen among the groups and no reports of serious adverse events.
"To the best of our knowledge, this study represents the first head-to-head comparison demonstrating the efficacy of curcumin in treating functional dyspepsia compared with omeprazole," the authors write. "Curcumin and omeprazole were both effective for functional dyspepsia and did not appear to have a synergistic effect."
Related Posts
Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer
WEDNESDAY, Feb. 23, 2022 (HealthDay News) -- In men receiving treatment for...
Higher Poststroke Glucose Levels Tied to Faster Cognitive Decline
FRIDAY, May 26, 2023 (HealthDay News) -- Higher poststroke glucose levels are...
Las muertes por fentanilo casi se cuadruplicaron en 5 años en EE. UU.
MIÉRCOLES, 3 de mayo de 2023 (HealthDay News) -- Las muertes por sobredosis en...
Solo 1 de cada 4 personas que sufren COVID prolongada se ha recuperado del todo un año después
LUNES, 25 de abril de 2022 (HealthDay News) -- Un año después de ser...